Home › Markets › Health Care › CNTX

Context Therapeutics Inc. (CNTX)

CNTX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.2750
-9.84% on the day
Market cap
$25.3M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerCNTX on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2021
SEC CIK0001842952
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52025-10-24
Latest annual report10-K2026-03-23
Latest quarterly / interim10-Q2026-08-05
Latest current report8-K2026-08-05
Latest proxyDEFA14A2026-04-28

Source: SEC EDGAR submissions feed, 307 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
MCRBSeres Therapeutics Inc.$2.53-5.60%$25.4M
ATOSAtossa Therapeutics Inc.$2.56+7.17%$25.5M
BYSIBeyondSpring Inc.$0.6067-1.43%$24.9M
SHPHShuttle Pharmaceuticals Holdings Inc.$5.18-4.95%$24.7M
QNTMQuantum Biopharma Ltd. Class B Subordinate Voting Shares$2.89+2.48%$24.5M
ABVCABVC BioPharma Inc.$0.9790-0.08%$26.1M
IMMPImmutep Limited$3.57-2.73%$26.3M
PBMPsyence Biomedical Ltd. Common Shares$4.55-4.01%$24.2M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier